These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15081876)

  • 1. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
    Rothbarth J; Koevoets C; Tollenaar RA; Tilby MJ; van de Velde CJ; Mulder GJ; Kuppen PJ
    Biochem Pharmacol; 2004 May; 67(9):1771-8. PubMed ID: 15081876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
    van der Veen AH; Seynhaeve AL; Breurs J; Nooijen PT; Marquet RL; Eggermont AM
    Br J Cancer; 1999 Feb; 79(3-4):433-9. PubMed ID: 10027309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
    Uzgare RP; Sheets TP; Johnston DS
    Anticancer Res; 2013 May; 33(5):1989-2000. PubMed ID: 23645748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
    Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas.
    Jonsson C; Stål P; Sjöqvist U; Akerlund JE; Löfberg R; Möller L
    Mutagenesis; 2010 Sep; 25(5):499-504. PubMed ID: 20551081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological detection of DNA damage caused by melphalan using monoclonal antibodies.
    Tilby MJ; Styles JM; Dean CJ
    Cancer Res; 1987 Mar; 47(6):1542-6. PubMed ID: 3815354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
    van Iersel LB; Verlaan MR; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Sparidans RW; Gelderblom H; Kuppen PJ; Tollenaar RA; van de Velde CJ
    Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.
    Rmali KA; Watkins G; Harrison G; Parr C; Puntis MC; Jiang WG
    Eur J Surg Oncol; 2004 Nov; 30(9):948-53. PubMed ID: 15498639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
    Tilby MJ; McCartney H; Gould KA; O'Hare CC; Hartley JA; Hall AG; Golding BT; Lawley PD
    Chem Res Toxicol; 1998 Oct; 11(10):1162-8. PubMed ID: 9778312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First results of a quantitative study of DNA adducts of melphalan in the rat by isotope dilution mass spectrometry using capillary liquid chromatography coupled to electrospray tandem mass spectrometry.
    Van den Driessche B; Esmans EL; Van der Linden A; Van Dongen W; Schaerlaken E; Lemière F; Witters E; Berneman Z
    Rapid Commun Mass Spectrom; 2005; 19(14):1999-2004. PubMed ID: 15954175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 elevation in relation to levels and cytotoxicity of mono- and bifunctional melphalan-DNA adducts.
    Gould KA; Nixon C; Tilby MJ
    Mol Pharmacol; 2004 Nov; 66(5):1301-9. PubMed ID: 15308759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
    Souliotis VL; Dimopoulos MA; Sfikakis PP
    Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of data-dependent acquisitions in the study of melphalan DNA adducts by miniaturized liquid chromatography coupled to electrospray tandem mass spectrometry.
    Van den Driessche B; Van Dongen W; Lemière F; Esmans EL
    Rapid Commun Mass Spectrom; 2004; 18(17):2001-7. PubMed ID: 15329868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques.
    Fichtinger-Schepman AM; Dijt FJ; Bedford P; van Oosterom AT; Hill BT; Berends F
    IARC Sci Publ; 1988; (89):321-8. PubMed ID: 3198216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
    Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
    J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between sensitivity of tumor cells to chemotherapeutic agent in vivo and in vitro: experiment with mouse lymphoma cells].
    Li CG; Li ML; Shu XH; Jia YJ; Liu YJ; Li M
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1576-8. PubMed ID: 17785116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of heat shock protein (HSP70) expression and Kupffer cell activity following thermal ablation of liver and colorectal liver metastases.
    Nikfarjam M; Muralidharan V; Su K; Malcontenti-Wilson C; Christophi C
    Int J Hyperthermia; 2005 Jun; 21(4):319-32. PubMed ID: 16019858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells.
    Bielawski K; Bielawska A; Sosnowska K; Miltyk W; Winnicka K; Pałka J
    Biochem Pharmacol; 2006 Jul; 72(3):320-31. PubMed ID: 16730667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of enzymatic, acidic and thermal hydrolysis of DNA on the occurrence of cross-linked melphalan DNA adducts.
    Van den Driessche B; Lemière F; Witters E; Van Dongen W; Esmans EL
    Rapid Commun Mass Spectrom; 2005; 19(4):449-54. PubMed ID: 15655794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.